Title:
FIVE-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND, AND USE THEREOF AS PROTEIN KINASE INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2023/155900
Kind Code:
A1
Abstract:
Provided in the present invention are a preparation and use of a five-membered and six-membered heterocyclic compound, and particularly provided is a compound as shown in the following formula I, wherein the definition of each group is as described in the description. The compound has TYK2 kinase inhibition or regulation and control activity, and can be used as a pharmaceutical composition for treating TYK2-related diseases.
More Like This:
Inventors:
ZHANG SHUYUN (CN)
CHENG ZHANLING (CN)
FENG ZHIYONG (CN)
HUANG LEI (CN)
JIANG LEI (CN)
JIN XIAN (CN)
LIU QIAN (CN)
LIU SHENGYANG (CN)
MAO XUDONG (CN)
QIAO ZHI (CN)
SHANG KE (CN)
SHOU JIANYONG (CN)
WU DANYI (CN)
XIE XIAOPING (CN)
XU YUAN (CN)
ZHANG YI (CN)
CHENG ZHANLING (CN)
FENG ZHIYONG (CN)
HUANG LEI (CN)
JIANG LEI (CN)
JIN XIAN (CN)
LIU QIAN (CN)
LIU SHENGYANG (CN)
MAO XUDONG (CN)
QIAO ZHI (CN)
SHANG KE (CN)
SHOU JIANYONG (CN)
WU DANYI (CN)
XIE XIAOPING (CN)
XU YUAN (CN)
ZHANG YI (CN)
Application Number:
PCT/CN2023/076922
Publication Date:
August 24, 2023
Filing Date:
February 17, 2023
Export Citation:
Assignee:
SHANGHAI ENNOVABIO PHARMACEUTICALS CO LTD (CN)
ENNOVABIO ZHEJIANG PHARMACEUTICALS CO LTD (CN)
ENNOVABIO ZHEJIANG PHARMACEUTICALS CO LTD (CN)
International Classes:
C07D487/04; A61K31/397; A61K31/4155; A61K31/5025; A61P9/00; A61P35/00; A61P37/00
Domestic Patent References:
| WO2018067432A1 | 2018-04-12 |
Foreign References:
| US20200231594A1 | 2020-07-23 | |||
| CN105992768A | 2016-10-05 | |||
| CN110938070A | 2020-03-31 | |||
| CN110938071A | 2020-03-31 |
Attorney, Agent or Firm:
XU & PARTNERS , LLC. (CN)
Download PDF: